Cargando…
The development and validation of a novel outcome measure to quantify mobility in the dysvascular lower extremity amputee: the amputee single item mobility measure
OBJECTIVE: This study describes the development and psychometric evaluation of a novel patient-reported single-item mobility measure. DESIGN: Prospective cohort study. SETTING: Four Veteran’s Administration Medical Centers. SUBJECTS: Individuals undergoing their first major unilateral lower extremit...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4978165/ https://www.ncbi.nlm.nih.gov/pubmed/27496697 http://dx.doi.org/10.1177/0269215516644308 |
_version_ | 1782447154226266112 |
---|---|
author | Norvell, Daniel C Williams, Rhonda M Turner, Aaron P Czerniecki, Joseph M |
author_facet | Norvell, Daniel C Williams, Rhonda M Turner, Aaron P Czerniecki, Joseph M |
author_sort | Norvell, Daniel C |
collection | PubMed |
description | OBJECTIVE: This study describes the development and psychometric evaluation of a novel patient-reported single-item mobility measure. DESIGN: Prospective cohort study. SETTING: Four Veteran’s Administration Medical Centers. SUBJECTS: Individuals undergoing their first major unilateral lower extremity amputation; 198 met inclusion criteria; of these, 113 (57%) enrolled. INTERVENTIONS: None. MAIN MEASURES: The Amputee Single Item Mobility Measure, a single item measure with scores ranging from 0 to 6, was developed by an expert panel, and concurrently administered with the Locomotor Capabilities Index-5 (LCI-5) and other outcome measures at six weeks, four months, and 12 months post-amputation. Criterion and construct validity, responsiveness, and floor/ceiling effects were evaluated. Responsiveness was assessed using the standardized response mean. RESULTS: The overall mean 12-month Amputee Single Item Mobility Measure score was 3.39 ±1.4. Scores for transmetatarsal, transtibial, and transfemoral amputees were 4.2 (±1.3), 3.2 (±1.5), and 2.9 (±1.1), respectively. Amputee Single Item Mobility Measure scores demonstrated “large” and statistically significant correlations with the LCI-5 scores at six weeks (r = 0.72), four months (r = 0.81), and 12 months (r = 0.86). At four months and 12 months, the correlation between Amputee Single Item Mobility Measure scores and hours of prosthetic use were r = 0.69 and r = 0.66, respectively, and between Amputee Single Item Mobility Measure scores and Trinity Amputation and Prosthesis Experience Scales functional restriction scores were r = 0.45 and r = 0.67, respectively. Amputee Single Item Mobility Measure scores increased significantly from six weeks to 12 months post-amputation. Minimal floor/ceiling effects were demonstrated. CONCLUSIONS: In the unilateral dysvascular amputee, the Amputee Single Item Mobility Measure has strong criterion and construct validity, excellent responsiveness, and does not exhibit floor/ceiling effects. |
format | Online Article Text |
id | pubmed-4978165 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | SAGE Publications |
record_format | MEDLINE/PubMed |
spelling | pubmed-49781652016-08-18 The development and validation of a novel outcome measure to quantify mobility in the dysvascular lower extremity amputee: the amputee single item mobility measure Norvell, Daniel C Williams, Rhonda M Turner, Aaron P Czerniecki, Joseph M Clin Rehabil Articles OBJECTIVE: This study describes the development and psychometric evaluation of a novel patient-reported single-item mobility measure. DESIGN: Prospective cohort study. SETTING: Four Veteran’s Administration Medical Centers. SUBJECTS: Individuals undergoing their first major unilateral lower extremity amputation; 198 met inclusion criteria; of these, 113 (57%) enrolled. INTERVENTIONS: None. MAIN MEASURES: The Amputee Single Item Mobility Measure, a single item measure with scores ranging from 0 to 6, was developed by an expert panel, and concurrently administered with the Locomotor Capabilities Index-5 (LCI-5) and other outcome measures at six weeks, four months, and 12 months post-amputation. Criterion and construct validity, responsiveness, and floor/ceiling effects were evaluated. Responsiveness was assessed using the standardized response mean. RESULTS: The overall mean 12-month Amputee Single Item Mobility Measure score was 3.39 ±1.4. Scores for transmetatarsal, transtibial, and transfemoral amputees were 4.2 (±1.3), 3.2 (±1.5), and 2.9 (±1.1), respectively. Amputee Single Item Mobility Measure scores demonstrated “large” and statistically significant correlations with the LCI-5 scores at six weeks (r = 0.72), four months (r = 0.81), and 12 months (r = 0.86). At four months and 12 months, the correlation between Amputee Single Item Mobility Measure scores and hours of prosthetic use were r = 0.69 and r = 0.66, respectively, and between Amputee Single Item Mobility Measure scores and Trinity Amputation and Prosthesis Experience Scales functional restriction scores were r = 0.45 and r = 0.67, respectively. Amputee Single Item Mobility Measure scores increased significantly from six weeks to 12 months post-amputation. Minimal floor/ceiling effects were demonstrated. CONCLUSIONS: In the unilateral dysvascular amputee, the Amputee Single Item Mobility Measure has strong criterion and construct validity, excellent responsiveness, and does not exhibit floor/ceiling effects. SAGE Publications 2016-08-04 2016-09 /pmc/articles/PMC4978165/ /pubmed/27496697 http://dx.doi.org/10.1177/0269215516644308 Text en © The Author(s) 2016 http://creativecommons.org/licenses/by-nc/3.0/ This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 3.0 License (http://www.creativecommons.org/licenses/by-nc/3.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access page (https://us.sagepub.com/en-us/nam/open-access-at-sage). |
spellingShingle | Articles Norvell, Daniel C Williams, Rhonda M Turner, Aaron P Czerniecki, Joseph M The development and validation of a novel outcome measure to quantify mobility in the dysvascular lower extremity amputee: the amputee single item mobility measure |
title | The development and validation of a novel outcome measure to quantify mobility in the dysvascular lower extremity amputee: the amputee single item mobility measure |
title_full | The development and validation of a novel outcome measure to quantify mobility in the dysvascular lower extremity amputee: the amputee single item mobility measure |
title_fullStr | The development and validation of a novel outcome measure to quantify mobility in the dysvascular lower extremity amputee: the amputee single item mobility measure |
title_full_unstemmed | The development and validation of a novel outcome measure to quantify mobility in the dysvascular lower extremity amputee: the amputee single item mobility measure |
title_short | The development and validation of a novel outcome measure to quantify mobility in the dysvascular lower extremity amputee: the amputee single item mobility measure |
title_sort | development and validation of a novel outcome measure to quantify mobility in the dysvascular lower extremity amputee: the amputee single item mobility measure |
topic | Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4978165/ https://www.ncbi.nlm.nih.gov/pubmed/27496697 http://dx.doi.org/10.1177/0269215516644308 |
work_keys_str_mv | AT norvelldanielc thedevelopmentandvalidationofanoveloutcomemeasuretoquantifymobilityinthedysvascularlowerextremityamputeetheamputeesingleitemmobilitymeasure AT williamsrhondam thedevelopmentandvalidationofanoveloutcomemeasuretoquantifymobilityinthedysvascularlowerextremityamputeetheamputeesingleitemmobilitymeasure AT turneraaronp thedevelopmentandvalidationofanoveloutcomemeasuretoquantifymobilityinthedysvascularlowerextremityamputeetheamputeesingleitemmobilitymeasure AT czernieckijosephm thedevelopmentandvalidationofanoveloutcomemeasuretoquantifymobilityinthedysvascularlowerextremityamputeetheamputeesingleitemmobilitymeasure AT norvelldanielc developmentandvalidationofanoveloutcomemeasuretoquantifymobilityinthedysvascularlowerextremityamputeetheamputeesingleitemmobilitymeasure AT williamsrhondam developmentandvalidationofanoveloutcomemeasuretoquantifymobilityinthedysvascularlowerextremityamputeetheamputeesingleitemmobilitymeasure AT turneraaronp developmentandvalidationofanoveloutcomemeasuretoquantifymobilityinthedysvascularlowerextremityamputeetheamputeesingleitemmobilitymeasure AT czernieckijosephm developmentandvalidationofanoveloutcomemeasuretoquantifymobilityinthedysvascularlowerextremityamputeetheamputeesingleitemmobilitymeasure |